Atlas Trials

Pancreatic Ductal Adenocarcinoma (PDAC)

78 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pancreatic Ductal Adenocarcinoma (PDAC)

RecordFirmDate
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS (NCT05379985)Revolution Medicines, Inc.2022-05-31
RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer (NCT04575363)CHU de Reims2021-10-18
EUS-RFA PANCARDINAL-1 Trial (NCT04990609)The University of Texas Health Science Center, Houston2021-08-13
Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer (NCT05201729)Ruijin Hospital2021-08-01
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer (NCT04883450)Kaiser Permanente2021-02-01
Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer (NCT05168254)Ruijin Hospital2021-01-01
Advanced Therapies for Liver Metastases (NCT04622423)IRCCS San Raffaele2019-11-06
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors (NCT04083599)Genmab2019-09-17
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer (NCT03977233)UNC Lineberger Comprehensive Cancer Center2019-06-12
Study on Single-cell Regulons Atlas of Pancreatic Ductal Adenocarcinoma (NCT06720454)Tiejun Ying2019-01-02
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors (NCT03811652)MedImmune LLC2018-12-20
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. (NCT03549000)Novartis Pharmaceuticals2018-07-18
Mesenchymal CTC Ratio Dynamics Predicts Response and Survival in Pancreatic Ductal Adenocarcinoma With Neoadjuvant/Conversion Therapy (NCT07329920)Guo ShiWei2018-07-10
Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC (NCT03032913)University Hospital, Bordeaux2017-02-15
Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study (NCT02782182)University of Chicago2016-06-28
Expanded Access to PCNAT-01 for Patients With Resected Pancreatic Ductal Adenocarcinoma Following Surgical Resection and Adjuvant Therapy (NCT07612930)Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.

Track Pancreatic Ductal Adenocarcinoma (PDAC) automatically

Every clearance here is in the API, with alerts when new ones post.